Tennessee SB 2125: Health Care - As introduced, allows those pharmacies required to submit a quarterly report to the board of pharmacy regarding the quantity of sterile compounded products dispensed in a defined time period to do so by electronic means. - Amends TCA Title 4; Title 5; Title 6; Title 7; Title 33; Title 56; Title 63 and Title 68.

Status: Assigned to General Subcommittee of Senate Commerce & Labor Committee (as of 2020-02-26)

State: Tennessee · Session: 111 · Bill: SB 2125

Subjects: Health Care

Sponsors: Reeves, Thompson

View Tennessee SB 2125 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.